Overview

Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal Syndrome

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
The overarching goal of this project is to improve the clinical quality of patients with Benzodiazepine-resistant alcohol withdrawal syndrome.
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Hospira, Inc.
Hospira, now a wholly owned subsidiary of Pfizer
Treatments:
Diazepam